Upload
others
View
12
Download
0
Embed Size (px)
Citation preview
CURRICULUM VITAE
Dr. N. RAGAVAN
MS (Gen Surg), FRCSEd (Surgery in General)
PGC in Teaching and Learning
MD(Uro-Oncology), FRCS(Urology)
Fellow In Minimally Invasive Urology
(Robotics and Laparoscopy)
Senior Consultant Urological Surgeon & UroOncologist
(Laparoscopy & Robotics)
Apollo Hospitals, Chennai
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
2
PERSONAL DETAILS NAME Dr. N. RAGAVAN
PHONE +919840014421
Email [email protected]
ACADEMIC QUALIFICATIONS
Degree College / University
Month and Year
MBBS
Sri Ramachandra Medical College and Research Institute (SRMC) Madras, India
January 1995
MS (Gen Surgery)
Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, India
December 1998
FRCS
Royal College of Surgeons of Edinburgh
February 1999
Postgraduate Certificate in Teaching and Learning in Clinical Practice
Edge Hill College, Lancaster University
May 2005
MD Lancaster University May 2006
FRCS (Urol) Royal College of Surgeons May 2009
Fellowship Minimally Invasive Urology (Robotics and Laparoscopy)
University of Leipzig
April 2011 &Sep 2012
CERTIFICATION GMC&CCT (Urol) 5208047 (Full)
USI R275 ASU R005 TMC 55311
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
3
AWARDS AND HONOURS
Best of BAUS – Poster no 90 , Manchester 2006
Brian Booth Research Prize - Rosemere Cancer Foundation, 2005
Best Poster award – Poster session 37 at EAU, 2005
Best Presentation prize - North West Trainee’s Research Meeting, 2004
Best young Scientist award -1993-94, State Medical Council for Science and Technology.
Gold medal in surgery -1993, SRMC, India.
Gold medal in anatomy -1990, SRMC, India.
Honours in Anatomy, Physiology and Biochemistry In the University and College examinations -1990.
Honours in Ophthalmology, Microbiology and Community Medicine In the University Examinations -1992.
GRANTS
Grant for fellowship from Prostate UK
Norman Gibbon Travelling Fellowship
Seedcorn funding by the research directorate of Lancashire Teaching Hospitals NHS Trust
Joint applicant with Dr A Hindley for Rosemere Cancer Foundation funding for my research project.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
4
CLINICAL EXPERIENCE
Post Hospital Period Consultants
Senior Consultant Urological Surgeon, Uro Oncologist
Apollo Hospitals Chennai
Sept 18 onwards
Independent
Senior Consultant Urological Surgeon, Uro Oncologist
Gleneagles Global Hospitals, Chennai
Nov 17- August 18
Independent
Consultant Urological Surgeon, Uro Oncologist
Apollo Hospitals, Chennai
Jan 13 Nov 17
Independent
Consultant Urological Surgeon And Uro Oncologist
Bradford Royal Infirmary
Aug11 Dec 12
Independent
Consultant Urological Surgeon And Uro Oncologist
Glan Clwyd Hospital
April11 to July 11
Independent
Fellowship in Laparoscopy and Minimally Invasive Urology
University of Leipzig
Jan 11 to March 11
Prof. Stolzenburg
Subspeciality in UroOncology and Laparoscopy
Wirral University Hospital
Feb 10 to Dec10
Mr Parr Mr Stephenson Mr Kumar
Subspeciality in UroOncology and Laparoscopy
Royal Liverpool Hospital
May 09 to Jan 10
Mr. Cornford
May 2009 FRCS ( Urol)
Specialist Registrar Urology (UroOncology / Laparoscopy)
Royal Liverpool Hospital
Feb 09 to Jan 10
Mr. Cornford
Specialist Registrar Urology (General/ Reconstruction/ Stones / Andrology)
Aintree Hospitals NHS Trust
Oct 07 to Jan 09
Mr Machin Mr Williamson Mr Baird
Specialist Registrar Urology (General / Stones/ Oncology/ Laparoscopy/ Incontinence)
Leighton Hospital Oct 06 to Sept 07
Mr. Irwin Mr Stubington Mr Javle
Specialist Registrar Urology (Andrology/ Incontinence)
Royal Liverpool Hospital
April 06 to Sept 06
Mr. Desmond
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
5
Specialist Registrar Pediatric Urology
Royal Liverpool Children’s Hospital
Oct 05 to March 06
Mr. Kenny Miss.McAndrew
Specialist Registrar Urology (General/ Oncology)
Royal Liverpool Hospital
July 05 to Sept 05
Mr. Cornford
Research Registrar Uro Oncology
Royal Preston Hospital, Preston
July 03 to June 05
Mr.Matanhelia Dr. Hindley
Hospital Registrar, Urology
Royal Preston Hospital
Jan 03 to June 03
Mr. Watson Miss. Blades Mr. Matanhelia
Senior SHO Urology (Mid grade cover in Urology, UroOncology)
Royal Preston Hospital,
Aug 02 to Dec 02
Mr. Watson Miss. Blades Mr. Matanhelia
Senior SHO urology (SHO on call for Urology, UroOncology and Surgery)
Leighton Hospital Crewe
July 01 to Aug 02
Mr. Irwin Mr. Javle Mr. Stubington
SHO Gen Surgery
Caithness Hospital Scotland
Feb 01 to July 01
Mr. Fisher
Registrar Gen Surgery
JIPMER India
Jan 00 to Jan 01
Prof. Srinivasan
Registrar Gen Surgery
PGIMER India
Jan 99 to Jan00
Prof. Katariya
SHO surgical rotation (General surgery, A&E, Urology and Renal transplant, other specialties)
PGIMER India
Jan 96 to Jan 99
Prof. Katariya Prof. Bose Prof. Sharma
Post graduate trainee Surgery (Urology, Gen surgery, Orthopedics)
MKCG Hospital India
April 95 to Jan 96
Prof. Subudhi Dr. Subudhi
PRHO (Medicine, Surgery, Obs&Gyne, Community medicine)
SRMC Hospital India
Jan 94 to Jan 95
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
6
Experience in Urology I work as a consultant urological surgeon with special interest in uro-oncology. I regularly perform major uro-oncological procedures utilising the modalities (robotic , laparoscopic and open surgery as appropriate) include radical nephrectomy, nephroureterectomy, nephron sparing surgery (partial nephrectomy), caval thrombus excision, radical prostatectomy, radical cystectomy with ileal diversion( including Intracorporeal), anterior pelvic exenteration, pelvic and retroperitoneal lymphadenectomy, neo-bladder reconstruction, penile cancer surgery ( glansectomy, partial , total amputation), Inguinal node dissection and testicular cancer surgery. I have substantiated my laparoscopic uro-oncology experience by completing laparoscopy and minimally invasive fellowship under Prof. Stolzenburg at University of Leipzig, Germany. I am performing Robotic surgery including radical prostatectomy robotic cystectomy and intracorporeal conduit, Robotic partial nephrectomy, RPLND, Nephroureterectomy , adrenelectomy , VVF repair and help gynaecologists during hysterectomy & sacrocolpopexy. Infact, I performed the first intracorporeal complete Nephroureterectomy at Chennai ( both upper and lower end), first Robotic RPLND for testicular Ca, Robotic Boari flap for uretric reconstruction & Extra Peritoneal Robotic Prostatectomy and Robotic Cystectomy + Intracorporeal Conduit , Intra corporeal Augumentation cystoplasty , Extraperitoneal segmental excision of ureter at Apollo Chennai..
I perform the full range of urological surgeries ( core urology) such as TURP , TURBT , Ureteroscopy , penoscrotal surgery However my area of interest is urooncology. My full experience since 2005 is available electronically. Prior to this, I have maintained a hand-written logbook. Experience in General surgery
I completed my postgraduate training from PGIMER, one of the premier institutes in India. I also worked a senior resident in PGIMER and in JIPMER. I gained invaluable experience in these institutions. I have performed appendicectomy, repair of hernia, cholecystectomy, ileostomy, colostomy, small and large bowel resection, perforation closure, thyroidectomy and mastectomy independently. I have assisted and performed (under supervision) in many major abdominal surgeries including pancreatectomy, oesophagectomy, abdominal perineal resection, hepatectomy and vascular procedures. I have maintained hand-written logbook of my experience from these institutions.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
7
RESEARCH EXPERIENCE Thesis Title An analysis of hormone- or carcinogen-metabolising enzyme expression in human prostate in relation to susceptibility to adenocarcinoma and an epidemiological investigation of lifestyle risk factors Sections of the work have been presented in AACR (2004, 2005, 2006), UKEMS (2004), BPG (2004, 2006), URS (2005), EEMS (2005) and EAU (2006). I have published part of the work in Cancer Letters, Biophysical Journal, Prostate Cancer and Prostatic Diseases and Prostate
Thesis Projects “Inter- and Intra - individual differences in the gene expression of phase I and phase II enzymes in the normal prostate”
To investigate whether a differential expression profile in phase I/II genes might explain zone susceptibility to CaP, we obtained tissue sets consisting of PZ and transition zone (TZ) of prostate. Levels of CYP1B1 and NAT1 were distinctly higher in PZ. Immunohistochemistry confirmed the presence of CYP1B1 and NAT1 in the prostate. “Survey of the incidence of major ailments amongst female partners of men diagnosed with prostate cancer: a pilot study” A questionnaire study into the risk of common cancers in female partners of CaP males in NorthWest England was conducted. Rates for breast, colorectal or lung cancer among female partners were similar to estimates. However, observed rates for breast or lung cancers among previous female partnerss were significantly (p
0.001) elevated “IR spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell”
The IR spectral signature of PZ and TZ was obtained using Fourier- transform infrared (FTIR) micro-spectroscopy Following spectroscopic analysis, plotted clusters and their loadings curves highlighted marked spectral variation in the region
containing DNA/RNA bands (1,490-1,000 cm-1). TZ cells appeared to align more closely with CaP cells while exhibiting marked structural differences compared to PZ cells.
In conclusion, the prostate gland possesses the metabolic machinery to activate pro-carcinogens. It is likely that environmental and/or dietary factors play an important role in the aetiology of CaP.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
8
Other Postgraduate projects “Economic consequences of Prostate and Bladder cancer in the UK” Method - Prospective analysis of the direct and indirect costs of the treatment of prostate and bladder cancer patients in one year (2001-02) at Royal Preston Hospital and for the UK using BAUS database. Direct costs are calculated on the basis of EAU guidelines and the indirect costs are calculated with the help of economics chart. The correlation of research investment to the cost of disease management was done. Results - Total costs for the treatment of prostate cancer were more than bladder cancer. However individual patients treatment cost was higher for bladder cancer. There was a substantial difference in the research investment for prostate cancer compared to bladder cancer. This has been published BJUI and a parts were presented at BPG, 2004 and EAU 2005. “A Randomised Controlled Trial comparing Lignocaine Peri-Prostatic Nerve Block (PPNB), Diclofenac suppository and both in Transrectal Ultrasound (TRUS) guided biopsy of prostate”
Method - Prospective randomised controlled trial with 55 patients in each group. This project was done at Leighton Hospital. Results - The patients in the combination group felt less pain during and after biopsy compared to the other groups. This study was presented in EAU 2003 and BPG 2004 and was published in J Urol “Efficacy of combined ESWL with percussion on lower pole stone clearance” Method - Prospective study done in 30 patients at Leighton hospital. Results - Initial results were promising in achieving good stone clearance by this combined method. “Effect of erythromycin and cisapride on gastric emptying of the vagally denervated intrathoracic stomach” (Part of MS dissertation) Method - Prospective randomised study of 19 post esophagectomy patients using radioisotope-labelled rice cakes to assess the empting of the denervated intrathoracic stomach was done at PGIMER, India. Results - Gastric emptying was significantly accelerated by cisapride.
Undergraduate project “Correlation study of BMI, Central obesity, Blood pressure and Metabolic disturbances in South Indian Population”
I was awarded the "Best young scientist in the state" Method -50 patients in each group were identified. Results -Hypertensive patients had higher incidence of hyperinsulinemia along with high body mass index.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
9
ONGOING PROJECTS
Vitamin D3 levels in patients with urinary stones
Radical prostatectomy – Single surgeon experience
Radical prosatetcomy – Multi-institution experience
PI for Phase IV trial of Inj Degarelix in Indian population
Enhanced recovery after major urological surgery
PUBLICATIONS Published
Ragavan N, Dholakia K, Ramesh M, Stolzenburg JU. Extraperitoneal vs. transperitoneal robot-assisted laparoscopic radical prostatectomy-analysis of perioperative outcomes, a single surgeon's experience. J Robot Surg. 2018 Jul 19.
Shah P, Ragavan N, Bhat S, Dholakiya K. Case report: Robot-assisted laparoscopic excision of giant ganglioneuroma of the adrenal gland. J Robot Surg. 2017 Jul 26.
Primary Intrarenal Yolk Sac Tumour . N Ragavan, K Dholakia, S Annapurneswari. IJU 2017 ; 33;2; 167
Robot assisted Laparoscopic excision of Organ of Zuckerkandl . N Ragavan, NK Narayanan, Malavizhi Ramesh, YVC Reddy. J. Robotic surgery. 2016. Dec;10(4):373-374
Prostate Biopsy for elevated PSA – Indian Perspective .N. Ragavan IJMR June 2014
Feasibility of minimally invasive radical prostatectomy in prostate cancer patients with high prostate-specific antigen: feasibility and 1-year outcomes Do M, Ragavan N, Dietel A, Liatsikos E, Anderson C, McNeill A, Stolzenburg
JU. Int J Urol. 2012 Oct;19(10):923-7.
Comments on the extraperitoneal approach for standard laparoscopic radical prostatectomy: what is gained and what is lost. Liatsikos E, Kyriazis I, Kallidonis P, Do M, Haefner T, Dietel A, Holze S, Ragavan N, Stolzenburg JU. Prostate Cancer. 2011
Clinical outcomes of laparo-endoscopic single-site surgery radical nephrectomy .Stolzenburg JU, Kallidonis P, Ragavan N, Dietel A, Do M, Thi
PH, Till H, Liatsikos EN. World J Urol. 2012 Oct;30(5):589-96.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
10
Constitutive expression of bioactivating enzymes in normal human prostate suggests a capability to activate pro-carcinogens to DNA-damaging metabolites. Martin FL, Patel II, Sozeri O, Singh PB, Ragavan N, Nicholson CM, Frei E, Meinl W, Glatt H, Phillips DH, Arlt VM. Prostate. 2010 Oct 1;70(14):1586-99.
“ High level of SOX9 in the prostate contributes to increased proliferation and can cooperate with PTEN loss to accelerate neoplasia formation” Martin K. Thomsen, Laurence Ambroisine, Sarah Wynn, Kathryn S Cheah, Christopher S. Foster, Gabrielle Fisher, Daniel M. Berney, Henrik Møller, Victor Reuter, Peter Scardino, Jack Cuzick, The Transatlantic Prostate Group, Narasimhan Ragavan, Paras B. Singh, Francis L. Martin, Christopher K. Butler, Colin S. Cooper and Amanda Swain
Cancer Res. 2010 Feb 1;70(3):979-87
“ Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study Paras B. Singh, Narasimhan Ragavan, Katherine M. Ashton, Prabir Basu, Sayeed M. Nadeem, Caroline M. Nicholson, R. K. Gopala Krishna, Shyam S. Matanhelia, and Francis L. Martin Asian J Androl. 2010 Mar;12(2):203-14
“Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: a UK hospital experience.” Singh PB, Nicholson CM, Ragavan N, Blades RA, Martin FL, Matanhelia SS.. BMC Urol. 2009 May 27;9(1):3.
“Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate” John K, Ragavan N, Pratt MM, Singh PB, Al-Buheissi S, Matanhelia SS,
Phillips DH, Poirier MC, Martin FL. Prostate. 2009;69(5):505-19
“Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to Guide Timing of Androgen Deprivation in Patients with T0-4 N0-2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891).” Ragavan N, Singh PB, Martin FL, Baird AD Eur Urol 2008;53:941-9.
“Re; The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. PB Singh, N Ragavan , FL Martin, SS
Matanhelia .BJU Int. 2009 Feb;103(4):553
“Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland.”
Noel EE*, Ragavan N*, Walsh MJ, James SY, Matanhelia SS, Nicholson
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
11
CM, Lu YJ, Martin FL. (*Joint first Authors) Prostate Cancer Prostatic Dis. 2008;11(2):173-80
“Identify the variables responsible for cluster formation in discriminant analysis of data derived from IR microspectroscopy of a biological sample” FL. Martin, MJ. German, E Wit, T Fearn, N Ragavan and HM. Pollock J Comput Biol. 2007 Nov;14(9):1176-84
“Gene expression profiling of the human prostate zones.” Ragavan N, Martin FL
BJU Int. 2007 Jan;99 (1):212 ( Letters to Editor)
“An observational study of cancers among female partners of UK-resident prostate cancer patients.” Ragavan N, Grover PL, Balasubramanian SP, Hindley AC, Matanhelia S, Martin FL. Cancer Lett. 2006 Oct 8;242(1):88-94
“Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell”
German MJ, Hammiche A, Ragavan N, Tobin MJ, Cooper LJ, Matanhelia
SS, Hindley AC, Nicholson CM, Fullwood NJ, Pollock HM, Martin FL. Biophys J. 2006 May;90(10):3783-95.
“A Randomised Controlled Trial comparing Lignocaine Peri-Prostatic Nerve Block (PPNB), Diclofenac suppository and both in Transrectal Ultrasound (TRUS) guided biopsy of prostate” N Ragavan, J Philip, SP Balasubramanium, J Desouza, C Marr, P Javle J Urol. 2005 Aug;174(2):510-13
“Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity” Morris JD, Pramanik R, Zhang X, Carey AM, Ragavan N, Martin FL, Muir GH
Cancer Lett. 2006 Jul 28;239(1):111-22
“Economic consequences of prostate and bladder cancer in the UK” VK Sangar*, N Ragavan*, SS Matanhelia, ME Watson, RA Blades (*Joint first authors) BJU Int. 2005; 95(1):59-63
“Is DRE essential for the follow up of Prostate cancer patients? Audit of 194 patients “ N Ragavan, VK Sangar, S Gupta, J Herdmann, SS Matanhelia, ME Watson,
RA Blades Biomed Central Urology .2005, 5:1 http://www.biomedcentral.com/bmcurol/
“CYP1B1 expression in prostate is higher in the peripheral than in the transition zone” N Ragavan, R Hewitt, LJ Cooper, KM Ashton, AC Hindley, CM Nicholson,
NJ Fullwood, SS Matanhelia, FL Martin. Cancer Letters 2004; 215: 69-78
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
12
“Impact of peripheral biopsies in maximising early prostate cancer detection in 8,10 or 12 core biopsy regimes” J Philip, N Ragavan, J DeSouza, CS Foster, P Javle
BJU Int. 2004; 93 (9): 1218-20
“Penile Metastases In The Presence Of Normal PSA Levels And Negative Bone Scan: A Case Report. “ N. Ragavan, P. Irwin: The Internet Journal of Urology. 2004. Volume 2
Number 1
http://www.ispub.com/ostia/index.php?xmlFilePath=journals/iju/vol2n1/penile.xml
Publications as a collaborator
Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG etal Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. Br J Cancer. 2016 Apr 12;114(8):945-52.
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet. 2015 Oct 1;24(19):5589-602.
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Eeles RA et al Nat Genet. 2009 Oct;41(10):1116-21.
Multiple loci on 8q24 associated with prostate cancer susceptibility. Eeles RA et al Nat Genet. 2009 Oct;41(10):1058-60.
Abstracts
Day Case Lap Nephrectomy – safety and feasibility – TAPASUCON 2018
PSM in Radical prostatectomy – Open versus Robotic technique TAPASUCON 2018
Radical Nephrectomy with IVC thrombectomy – 5 year experience , USICON 2018
Modified Brickers anastomosis for Ileal conduit diversion – point of technique , USICON 2018
Extraperitoneal Robot assisted uretric tumour excision and reimplant- case report . USICON 2018
Does Extrapritoneal robotic prostatectomy favour early bowel recovery. N.Ragavan, USICON 2017
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
13
Outcomes of Robotic Partial Nephrectomy for T1b/ T2 RCC . N. Ragavan USICON 2017
Germ cell tumour of the kidney - Case report . N Ragavan USICON 2016 Vol 32 , Suppl 1
Robot Assisted Laparoscopic excision of Organ of Zuckerkandl . N Ragavan USICON 2016 Vol 32 , Suppl 1
Robot Assisted Lap excision of Intra Renal tumour – Role of Intraoperative ultrasound . N Ragavan USICON 2016 Vol 32 , Suppl 1
Renal Plasmacytoma – Case report . N Ragavan , Gyvi Gaurav USICON 2015, IJU supplements
Leipzig Bradford Technique of Robotic Radical Prostatectomy USICON 2014. N Ragavan , S Addla, JU Stolzenburg , IJU Supplements1 Vol 30
Total Intracorporeal Nephrouretrectomy . USICON 2014. N Ragavan. , IJU Supplements
Long term outcomes of AUS in children with Neuropathic bladders Surange R, Ragavan N, Baird A. Eur urol Supplements 2010.
Molecular and optical profiling of prostate tissues derived from populations with differential risk of prostate adenocarcinoma. PB Singh, II Patel, N Ragavan, SS Matanhelia, FL Martin.
BAUS section of Oncology meeting , 2009. BJMSU 2009
Gene expression of Phase I and Phase II metabolizing enzymes and PAH- DNA adduct formation in human prostate as risk factors in prostate cancer etiology Kaarthik John, Paras B. Singh, M. Margaret Pratt, Narasimhan Ragavan,
Katherine C. Cole, Shyam S. Matanhelia, David H. Phillips, Miriam C. Poirier, Francis L. Martin
EMS 38th Annual meeting 2008 , Abstract book ; 557
Immunohistochemical Determination and Comparison of Polycyclic Aromatic Hydrocarbon (PAH)-DNA Adduct Levels in Peripheral and Transition Zones of Human Prostate M. Margaret Pratt, Kaarthik John, Paul Sirajuddin, Narasimhan Ragavan, Francis L. Martin, Ofelia A. Olivero and Miriam C. Poirier EMS 2007
Pratt MM, Sirajuddin P, Castle PE, Phillips DH, Afework S , MacLean AB,
Ragavan N, Martin FL, Olivero OA, Poirier MC
Imaging and semiquantitation of polycyclic aromatic hydrocarbon (PAH)-DNA
adducts in human reproductive tissues.
Environmental and molecular mutagenesis, 47 (6): 475-475 Jul 2006
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
14
Prostate tissues for research - the way we do it N Ragavan, CM Nicholson, SS Matanhelia, FL Martin BPG abstract book (Prostate cancer and Prostatic diseases)
Vasovasotomy- A simpler way ! Ragavan N, Matanhelia M, Matanhelia S
BJUI suppl, 2006;97:72 (Abstract 90)
Wardill’s test – a useful predictor of voiding flow following removal of urinary catheter. J Philip, A Samsudin, N Ragavan, SR Stubington.
BJUI suppl, 2006; 97:78 (Abstract 102)
An observational study of cancers among female partners of UK-resident prostate cancer patients Ragavan N, Grover P, Balasubramanian SP, Hindley AC, Matanhelia SS,
Martin FL. Eur Urol Suppl 2006;5(2):165
Expression of hormone-/carcinogen-metabolising enzymes in the prostate: clues into peripheral-zone susceptibility? Ragavan N, Hewitt R, Hindley AC, Nicholson CM, Matanhelia SS, Martin FL
Eur Urol Suppl 2006;5(2):165
Imaging and semiquantitation of polycyclic aromatic hydrocarbon (PAH)-DNA adducts in human cervix, vulva, placenta and prostate using immunohistochemistry (IHC) and the Automated Cellular Imaging System (ACIS) . M Pratt, P Sirajuddin, PE Castle, DH Phillips, S Afework, AB MacLean, N Ragavan, FL Martin, RJ Sram, DK Manchester, OA Olivero and MC Poirier. Abstract 2058 AACR Abstract book 2006; 486
A susceptibility-to-adenocarcinoma signature in prostate tissue using high-resolution synchrotron IR micro-spectroscopy.
German, M.J., Ragavan, N., Hammiche, A., Tobin, M., Pollock, H., and Martin, F.L. (2005) European Journal of Genetic Toxicology
Modernisation of Prostate Cancer Follow-up: Shifting paradigms The Nurse Specialist and the Role of DRE Ragavan N, Sangar VK, Gupta S, Matanhelia SS, Watson ME, Blades RA Prostate Cancer Prostatic Diseases 2005 (8) 385
Lignocaine Periprostatic nerve block (PPNB) – With or Without Rectal Diclofenac for Transrectal Prostatic biopsy. Randomised Controlled Trial N Ragavan, J Philip, J DeSouza, C Marr, P Javle. Prostate Cancer Prostatic Diseases 2005 (8) 395
Does diclofenac increase the bleeding complications after prostatic biopsy? N Ragavan, J Philip, J DeSouza, C Marr, P Javle. Prostate Cancer Prostatic Diseases 2005 (8) 395
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
15
Is DRE essential for the follow up of prostate cancer patients? A Prospective audit of 194 patients Ragavan N, Sangar V, Gupta S, Herdmann J, Matanhelia S, Watson M.
Eur Urol suppl 4 (2005);3:79
Economics of bladder cancer management in the UK; A case for further investment in research. N Ragavan, VK Sangar, SS Matanhelia, ME Watson, RA Blades.
Eur Urol suppl 4 (2005);3:162
CYP1B1 expression and peripheral-zone susceptibility to prostate adenocarcinoma: comparisons with other carcinogen/hormone-metabolising enzymes Francis L Martin, Narasimhan Ragavan, Rebecca Hewitt, Andrew C Hindley,
Caroline M Nicholson, Shyam S Matanhelia AACR abstract book. Page 162 March 2005
CYP1B1 expression is higher in the peripheral zone compared to the transition zone: a difference underlying zonal susceptibility to prostate adenocarcinoma? N Ragavan, R Hewitt, AC Hindley, CM Nicholson, SS Matanhelia, FL Martin
Prostate Cancer and Prostatic Diseases (2006) 9, 310-335
The Economic Consequences of Prostate Cancer in the UK N Ragavan, VK Sangar, SS Matanhelia, ME Watson, RA Blades
Prostate Cancer and Prostatic Diseases (2006) 9, 310-335
Inter-and intra-individual variations in prostate CYP1B1 expression suggest a role in peripheral-zone susceptibility to adenocarcinoma N Ragavan, R Hewitt, AC Hindley, CM Nicholson, SS Matanhelia, FL Martin
Mutagenesis.2004;19(6):503 (Abstract 13)
Pre-existing Levels of CYP1B1 Expression in Human Prostate Tissues
Modulated by 17-Oestradiol in the Presence of Benzo[a]pyrene Martin FL, Ragavan N, Hewitt R, Nicholson, CM, Matanhelia SS, Hindley AC, McMillan TJ. AACR abstract book. Page 95 March 2004.
Rectal Diclofenac along with periprostatic nerve block provides sustained pain relief after TRUS Biopsy N Ragavan, J Desouza, P Javle .
Euro Urology suppl 2(2003): 1:106.
Orthotopic neobladder vs. Ileal conduit diversion - A quality of life based comparison Philip J, Ragavan N, DeSouza J, Owen DA, Javle P J Urol 2004 .171; No 4, (Supplement): 15 Abstract no 57.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
16
PRESENTATIONS Oral presentations
Current status of Intravesical therapy in NIMBC. HS Bhatt Oration, Coimbatore Nov 2017
Subtelities and nuances in the management of small renal masses. SZUSICON, Manipal, 2017
Extra peritoneal vs. Transperitoneal robotic radical prostatectomy – Single surgeons exerience . SZUSICON, Pondy, 2016.
Advanced Prostate Cancer – way forward . Pondy renal sciences club – Pondicherry – June 2016
Management advanced prostate cancer. Madras Urological Society. May 2016
Robotics in Prostate Cancer Tiruchi Oncology club Jan 2015
Robot assisted excision of organ of Zuckerkandl – USICON 2016
Robot assisted excision of intrarenal tumour with ultrasound guidance – USICON 2016
Germ cell tumour of kidney – USICON 2016
Asymptomatic men with low grade prostate cancer – management – second opinion debate . Prof HS Bhat Oration , Managalore Nov 2015
Extraperitoneal Robot assisted Laparascopic radical prostatectomy , TAPASU 2015 , Pondicherry
Robotic excision of Organ of Zuckerkandl – Case report , TAPASU 2015
Germ cell tumour of the kidney , Case report TAPASU 2015
Robotic excision of complete intra renal tumour , Robotic council of India , AIMS , Kochi Sept 2015
Radical Prosatetctomy in high risk disease , AIMS , Kochi May 2015
Renal Plasmacytoma – Case report , USICON 2015,
Leipzig – Bradford Technique of Robotic Radical prostatectomy – USICON, Delhi Jan 2014
Total Intracorporeal Nephroureterectomy . USICON, Delhi Jan 2014
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
17
Leipzig – Bradford Technique of Robotic Radical prostatectomy – TAPASU , Tiruchi, Sep 2013
Open Vs Lap Vs Robotic Radical Prostatectomy – Single Surgeons experience - TAPASU , Tiruchi, Sep 2013
Total Intracorporeal Robotic Nephroureterectomy - TAPASU , Tiruchi, Sep 2013
The presenting features of Penile Carcinoma-In-Situ and response to treatment with topical 5-Flurouracil - Norman Gibbon Meeting , Liverpool Feb 2011
Bone scan as a screening tool for prostate cancer patients – Is it useful? Norman Gibbon Meeting , Liverpool Feb 2011(second author)
Intravesical injection of Botulinum toxin A in treatment of idiopatic detrusor overactivity: a review of 5 years’ activity. Norman Gibbon Meeting , Liverpool Feb 2011 (second author)
Early Feeding after cystectomy - ? A feasible option Normand Gibbon Meeting, Liverpool Feb 2010
An analysis of hormone- or carcinogen-metabolising enzyme expression in human prostate in relation to susceptibility to adenocarcinoma . Invited speaker, Biomedical conference . India, August 2009
Intra- , Inter-individual and Inter -Ethinic differences in the hormone- and carcinogen-metabolism in the prostate . NorthWest Urology meeting , Warrington , May 2009
Isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy has a high-risk association with prostate cancer: a UK hospital experience. Norman Gibbon Meeting , Liverpool , January 2008 ( second author)
Hormone- and carcinogen-metabolism in cancer-free prostate: peripheral- Vs. transition-zone differences in quantitative whole-tissue gene expression Norman Gibbon Meeting, Liverpool, January 2005
A susceptibility-to-adenocarcinoma signature in prostate tissue using high-resolution synchrotron IR micro-spectroscopy European Environemental Mutagensis Society (second author)
Inter-and intra-individual variations in prostate CYP1B1 expression suggest a role in peripheral-zone susceptibility to adenocarcinoma. North West Trainees’ Research Meeting, Manchester, September 2004.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
18
The role of chemical carcinogens in the etiology of prostate cancer. Annual Research Conference. LSCRN, Preston, September 2004.
Inter-and intra-individual variations in prostate CYP1B1 expression suggest a role in peripheral-zone susceptibility to adenocarcinoma. UKEMS, Loughborough, July 2004.
Lignocaine Periprostatic nerve block (PPNB) – With or Without Rectal Diclofenac for Transrectal Prostatic biopsy. A Prospective Randomised Controlled Trial. BPG Meeting, London, March 2004.
Xenobiotic metabolism in the aetiology of prostate cancer. North West Trainees’ Research Meeting, Manchester, April 2004.
Economic consequences of prostate and bladder cancer. North West Trainees’ Research Meeting, Manchester, March 2003.
Leading towards nurse led prostate cancer follow up.North West Trainees’ Research Meeting, Manchester, March 2003.
Economic consequences of prostate and bladder cancer (Protocol) North West Trainees’ Research Meeting. Manchester, September 2002.
New bladder available at your local hospital. Liverpool and Northwest Surgeons Meeting, Liverpool, November 2001.
Combined oral and poster presentation
Loupe-assisted vasovasostomy with removable stent yields high patency rates. BAUS, Manchester, June 2006
An observational study of cancers among female partners of UK-resident prostate cancer patients EAU, Paris, April 2006
Expression of hormone-/carcinogen-metabolising enzymes in the prostate: clues into peripheral-zone susceptibility? EAU, Paris, April 2006
Is DRE essential for the follow up of prostate cancer patients? A Prospective audit of 194 patients
EAU, Istanbul, March 2005.
Economics of bladder cancer management in the UK; A case for further investment in research. EAU, Istanbul, March 2005.
Hormone- and carcinogen-metabolism in cancer-free prostate: peripheral- Vs. transition-zone differences in quantitative whole-tissue gene expression Urological research Society Meeting, London, January 2005.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
19
CYP1B1 expression and peripheral-zone susceptibility to prostate adenocarcinoma: comparisons with other carcinogen/hormone-metabolising enzymes AACR 2005 ( Second author)
CYP1B1 expression is higher in the peripheral zone compared to the transition zone: a difference underlying zonal susceptibility to prostate adenocarcinoma? Prostate cancer - A meeting of minds (BPG), Manchester, November 2004.
Rectal Diclofenac along with periprostatic nerve block provides sustained pain relief after TRUS Biopsy. EAU conference, Madrid, March 2003
Pre-existing Levels of CYP1B1 Expression in Human Prostate Tissues
Modulated by 17-Oestradiol in the Presence of Benzo[a]pyrene. AACR, Florida, March 2004 (second author).
Orthotopic neobladder vs. Ileal conduit diversion - A quality of life based comparison. AUA, San-Francisco, May 2004 (second author).
Poster presentation
Prostate tissues for research - the way we do it BPG meeting – Cardiff, September 2006
CYP1B1 expression is higher in the peripheral zone compared to the transition zone: a difference underlying zonal susceptibility to prostate adenocarcinoma? Meeting of Minds (BPG) – Manchester, November 2004
The Economic Consequences of Prostate Cancer in the UK Meeting of Minds (BPG) – Manchester, November 2004
Pre-existing Levels of CYP1B1 Expression in Human Prostate Tissues
Modulated by 17-Oestradiol in the Presence of Benzo[a]pyrene. North West Cancer Research Foundation Meeting, Liverpool, May 2004.
Modernisation of Prostate Cancer Follow-up: Shifting paradigms The Nurse Specialist and the Role of DRE. BPG Meeting, London, March 2004
Does diclofenac increase the bleeding complications after prostatic biopsy? BPG Meeting, London, March 2004.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
20
TRAINING VIDEOS
Laparoscopic Endoscopic Single site Surgery – Radical Nephrectomy
Laparoscopic Endoscopic Single site Surgery - Bladder diverticulectomy AUDIT EXPERIENCE Hospital audits
Radical Prostatectomy: Oncological and Functional Outcomes. It is rolling audit at BTHFT, retrospective in nature. This audit highlighted that our positive margin rate and complications were acceptable but there were higher proportion of patients with pT3 disease.
Radical Cystectomy: Early and Late Outcomes. Rolling audit with retrospective and prospective data collection. This audit concluded our morbidity and mortality rates were in line with world literature. Further, there was not much difference in morbidity and progression free survival with or without neoadjuvant chemotherapy.
Penile Carcinoma in Situ – Presenting features and treatment with 5FU Methods – Retrospective case notes analyses of 28 patients. Results – The treatments included circumcision + 5FU (11), radical circumcision (± local glans excision)(16) and radical circumcision and skin grafting(1). 8 patients (72.7 % ) complete response while 3 had incomplete response ( on repeat biopsy; CIS = 2, CIS with micro invasion = 1). At a mean follow up of 21.1 months 3 recurrences (2 in the 5FU non complete responders and 1 following radical circumcision) were noted. Conclusion - Treatment with topical 5 FU can be significantly painful. Failure to achieve complete response carries risk of previously undetected invasive cancer and of subsequent recurrences
Value of Frozen section (FZ) in patients undergoing penis preserving surgery Method – Retrospective analyses of database and case notes at Arrowe Park Hospital. Results – FZ was performed in 10/25 patients (40%), of which it was positive in 4/10 patients (40%). No recurrences were noted in 22 patients (88%) (Includes all patients who had positive FZ and further excision) while 1 (4%) patient had local recurrence (FZ negative) and 2(8%) had systemic recurrence (FZ negative =1 and FZ not taken =1) Recommendations - FZ is a valuable tool particularly, when used in selected circumstances as it would avoid further anaesthetic requiring completion of excision.
Audit on the outcomes of early feeding programme after cystectomy. Method – Retrospective and prospective analyses of the outcomes, and short term complications following early feeding programme after cystectomy
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
21
Results – The complications appears similar to delayed feeding. There is tendency of early discharge in patients
Role of bone scans in the contemporary management of prostate cancer patients Methods - Retrospective review of prostate cancer patients undergoing bone scan over 1 year period (June 07- May 08). Results - 166 patients underwent bone scans (new = 53, f/u = 113) with clear results in (142 (85.5 %) (positive for met s = 36, negative = 106). In 14.5% of patients (n=24) scan was equivocal requiring secondary assessment to clarify the outcome (negative = 16, positive = 6, inconclusive = 2). Conclusions - Bone scan is a useful tool but has limitations. Newer modalities (MR survey) could be considered for patients in future
Outcomes of diagnostic cystoscopies – When should we do? Method – Prospective data collection at flexible cystoscopies to assess their outcomes at Aintree Hospitals NHS Trust Results – 24% of haematuria patient had a significant finding in the Flexi including 12% had bladder tumour. However in non-haematuria patients only 2% had bladder tumour. While, Flexible cystoscopy was appropriate as a 1st line investigation in all patients presenting with haematuria, it was deemed so in 32% of Non-Haematuria patients. Recommendations – 1. One stop haematuria service was needed to streamline service. 2. Careful referral is required for patients without haematuria
Outcome of reversal of vasectomy – Leighton Hospital Method - Retrospective audit of all vaso-vasostomy done by single surgeon (2000-2006) combined with a simple questionnaire. Results – 6/7 patients who had semen analyses were positive for sperms . However only 2/11 patient achieved pregnancy by natural methods. Recommendations – Routine semen analyses 6-12 months after vasectomy reversal was recommended. This audit was also a useful tool in counselling future patients for the procedure
Audit of laparoscopic nephrectomy in children – Feasibility for the procedure to be done as a day case Method – Retrospective case note analysis at Alder Hey Children’s Hospital. Results – The operative and post operative recovery along with analgesics requirements were assessed in 44 patient who had Lap Nephrectomy. It emerged that majority of them were fit for discharge soon after the procedure. Recommendations - In majority of the children with no pre exiting medical ailments, Lap nephrectomy can be offered as a day case.
Audit of the Nurse led prostate cancer follow up clinic Method - Retrospective audit at Royal Preston Hospital. Results - 231 patients seen over 6 months. The factors influencing changes in the management were PSA trend (15), LUTS (7), bone pain (5), DRE alone –
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
22
nil. However DRE along with PSA influenced a change in the management in 6 patients Recommendations – Nurse led clinic run parallel to the consultant clinic with a protocol to do DRE if there is change in PSA or onset of new symptoms was effective.
The value of DRE and PSA in the follow up of patients with prostate cancer. Method - Prospective audit at Royal Preston Hospital. Results - 194 patients follow up was audited over 4 months. The factors influencing change in the management were PSA trend (27), LUTS (10), bone pain (4), DRE change (2) and others (4). Recommendations - The PSA trend is the most common factor influencing the change in the management. The audit influenced the initiation of nurse led prostate cancer follow up clinic in the hospital.
The immediate postoperative complications and recatheterisation rates after TURP. Method - Prospective audit of 50 patients over 4 months at Leighton Hospital Results - 22 % of patients had postoperative hematuria, 12 % had infection and 24 % of patients failed TWOC. Recommendations – Better case selection, rigid antiseptic measures and antibiotic cover during the procedures were decided to be implemented.
The value of C-reactive protein and WBC in acute abdomen at Caithness General Hospital. Method - Prospective audit of 66 patients over 6 months. Results - CRP did not have advantage over WBC measurement Recommendations - Practice of routine CRP measurements was stopped.
External duodenal fistula following surgery for ulcer perforation at Postgraduate Institute of Medical Education and Research (PGIMER). Method - Retrospective analysis of 13 patients treated over 5 years. Results - Mortality was 53.8 % and enteral nutrition was the corner stone of successful therapy. Recommendations - Change of the practice to more conservative management of such patients with enteral nutrition was adopted.
Regional audits
I collated the data on behalf of Arrowe Park Hospital for the North West regional audit on penile cancer - May 2010
I presented the literature review and acted as local expert for the North West Regional audit on Radical nephrectomy –Nov 2009
I collected the data on behalf of Leighton hospital for the North West regional audit on epidydimo orchitis, management of male infertility and management of erectile dysfunction. 2002
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
23
National Audit
I collated the data on behalf of Arrowe Park Hospital for National Penile cancer audit on patients with N2 and N3 disease. 2010
INVITED LECTURES I have given lectures in many medical and public forums including IMA,s, Rotary clubs, scientific meetings etc Few salient ones include
Robotics and Artificial Intelligience – Biomedical conference , Tiruchi Nov 2017
Intravesical Chemotherapy – HS Bhatt Oration . Coimbatore . Oct 2017
Robotic prostatectomy . High precision oncology meeting Kochi
Robotics in Urology –Global and Indian Scenario – RUFCON 2017
Point of technique and advantages of extra peritoneal robotic radical prostatetcomy. Karnataka Urology Association meet Goa Sept 2016
Radical prostatetcomy in high risk prostate cancer . Master class in Urooncology Kochi Sept 2016
Surgery in advanced prostate cancer . Masterclass in Urooncology Sept 2016 Kochi
HSBhat Oration – Nov 2015
Robotic council of India meeting 2015
Screening for prostate cancer – Mumbai 2014
Radical Prostatetcomy – TAPASU Urooncology meet – Tiruchi 2014
Radical Prostatetcomy Versus Radical Radiotherapy – Global Prostate Centre – Bangalore
Prostate Cancer – Nigerian Urology Association , Nigeria
Robotics – Railway Hospital, Chennai
POSTGRADUATE EDUCATION COURSES CONDUCTED
Critical care course for surgeons . Sept 2017 at Chennai , Dec 2017 at Coimbatore
Introduction to UroOncology – Oct 2017 , Chennai
Point Counter Point – Debates in Prostate Cancer – July 2018
Bladder cancer update April 2018 COURSES
Robotic Console surgeon training - Paris June 2012
Robotic Training day at UCL – London , Oct 2012
Management Course – Mersey Deanery July 2010
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
24
Wet lab course – Rotterdam Jun 2010
Masterclass in Pelvic Laparoscopy – Middlesbrough March 2010
Training the Trainers – Feb 2010
Developing medical leaders – Liverpool Oct 2009
FRCS Viva course – Oxford March 2009
Laparoscopy – Dry Lab course – Rhyl, March 2008
Green light Laser course – Rhyl , 2007
Leadership and management skills for SpR’s – Liverpool, Oct 2007
Spinal cord Injury Course - Sheffield, May 2007
Interview skills for SpR’s – Liverpool , April 2007
Renal failure course , Manchester , BAUS , June 2006
Renal Transplantation course , Manchester , BAUS , June 2006
Paediatric Urology course, Cambridge , September 2005
Ureteroscopy Skills Course, Harrogate, BAUS June 2004
Scientific basis of urology, London, December 2003
Statistical methods in health research, Lancaster, November 2003
Basic Laparoscopy, Manchester, BAUS June 2003
Ultrasound for urologist, Madrid, EAU March 2003
Practical skills for urological surgeons, London, November 2002
European computer driving license, Royal Preston Hospital
Advanced course on urodynamics, Manchester, April 2002
ATLS course, Coventry, June 2001
Introductory course on GIA staplers, PGIMER, April 1999
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
25
CONFERENCES AND MEETINGS
TAPASU 2018 Kodaikanal
USICON , Jaipur 2018
ICC Bangalore Dec 2017
SZUSICON July 2017
TAPASU August 2017
RUFCON Mumbai April2017
Apollo Cancer Conclav Hyderabad 2017
KUA – Goa 2016
Masterclass in Urooncology Kochi 2016
TAPASU Yercaud 2016
SZUSICON Pony 2016
USICON , Hyderabad, 2016
Prof HS Bhat oration Mangalore 2015
TAPASU Pondicherry 2015
SUZICON Vizag 2015
UroOncology meet – Amritha Institute , Kochi 2015
Urooncology workshop and meeting , Mumbai 2014
Midterm CME – TAPASU , Tiruchi 2014
USI 2014
TAPASU 2013
BAUS Annual conference Liverpool 2011
Norman Gibbon Meeting , Liverpool Feb 2005 – 2011
BAUS Annual Conference , Manchester June 2010, June 2008 , June 2006 and June 2003
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
26
BAUS section of Oncology meeting , Birmingham , Nov 2009
SURG ,Liverpool Sept 2009
New Frontiers in Biomedical Sciences , India , August 2009
BAUS Annual Conference, Glasgow, June 2009 and June 2007
British Prostate Group meeting, Cardiff, September 2006
BAUS Annual conference , Manchester , June 2006
Annual EAU conference , Paris , April 2006
Long term sequel of Inter sex disorders , RCOG, London Dec 2005
Annual EAU conference , Istanbul , March 2005
Urological Research Society meeting. London, January 2005
Meeting of Minds (BPG). Manchester, November 2004
UK Environmental Mutagen Society. Loughborough , July 2004
BAUS Annual conference. Harrogate, June 2004
British Prostate Group meeting. London, March 2004
Annual EAU conference. Madrid, March 2003
3rd North West Urology Group meeting. Manchester, November 2002
North West Trainees’ Research meeting. Manchester, September 2002, March 2003, September 2003, March 2004, September 2004
North West urology audit meeting. Manchester, March 2002
Liverpool and North West surgeons meeting. Liverpool, November 2001
TEACHING EXPERIENCE Postgraduate Certificate in Teaching and Learning in Clinical practice.
I have a liking for teaching and therefore take special interest. I have completed the postgraduate certificate in teaching and learning and apply it in day to day practice
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
27
I have done lectures for medical students as well as non medical students (BSc students at Lancaster University). I have also done – one-one teaching, small group discussion and bedside teaching I also actively train my juniors’ in general clinical and operative practice. I have devised a rota / micro curriculum for medical students incorporating the learning objectives (corresponding to their year of training). I played an active role in revising the curriculum for undergraduate students I have compiled a “Urology Pack” for FY and ST Doctors. I also take an active role in improving my own teaching skills and therefore obtain feedback from the taught group. I have taken an active part in the revision of urology curriculum for undergraduate students at Liverpool Medical School. I am a trainer and thesis guide for DNB urology programme I am an examiner for MRCS exams
TEAM WORKING My role of team leader I was the STEC representative and regional teaching coordinator. I lead by example of dedication and enthusiasm. I appropriately delegate topics prioritising the training needs. I engaged in a consultation process involving the trainees and trainers demonstrating my inclusive leadership trait. I have also devised an evaluation form to improve performance based on feed-back My role as a team player This is best highlighted at Specialist MDT meetings. As a consultant, I not only highlight the salient clinico-radiological findings but also streamline investigations and management care plans in coordination with specialist nurses. This ensures and facilitates seamless discussions in MDT forums focusing on optimising patient outcomes. As a keen team player, I also follow up on these care plans and ensure timely implementation.
MANAGEMENT
I have revised clinical pathways at BTHFT; TRUS pathway, cancer pathways and TWOC pathways.I was also the audit lead during my tenure at BTHFT. Previously, I had actively involved in streamlining the work in the local hospitals. I have therefore devised Urology Pack for FY and ST doctors, Rota / Micro-curriculum for Medical Students and devised a proforma for reporting Urodynamic studies.
CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)
28
I was an elected member of the “Doctors Mess” at the Medical school. The role involves active liaising with other members of the group as well as the students and the accommodation officers, plan out strategies for effective utilization of resources and ensure harmony in the working atmosphere.
I have worked closely with my consultants and have helped to initiate mortality and morbidity meeting in Aintree as well as at Royal Liverpool Hospital
MEMBERSHIP OF LEARNED SOCIETIES
British Association of Urological Surgeons
European Association of Urology
BAUS section of Oncology
USI
ASU
TAPASU
IT SKILLS I am well versed with windows operating systems and its applications. I have completed ECDL certification course.
PERSONAL ATTRIBUTES, HOBBIES AND INTERESTS
I am a person and who can make friends easily. I respect all the members of my team including my colleagues, secretarial, nursing and ancillary staff understanding their individual contributions to the patient care and the smooth functioning of the NHS.
At work, I believe in dedication and sincerity, with patients at the center of the care we provide. I am willing to step in and support my colleagues and staff at the time of need and difficulties
Outside hospital, I believe in my personal space and my contribution to my family.
I have varied interests including hill walking, jogging and listening to music.
I believe in keeping fit and I jog 2 miles a day.
My avidity to explore nature has encouraged me to travel far and wide.
CAREER OBJECTIVE My clinical interests are Uro-Oncology and General Urology. My research interests lies in the management of urological cancers especially prostate I believe in training and clinical education as an integral part of practice and would like to actively be involved in both undergraduate and postgraduate education.